Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery Including a Corneal Endothelial Cell Sub-study

ClinicalTrials.gov ID: NCT04810962

Public ClinicalTrials.gov record NCT04810962. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 3:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of APP13007 for the Treatment of Inflammation and Pain After Cataract Surgery, Including a Corneal Endothelial Cell Sub-study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase 3 study will evaluate APP13007 in comparison to the matching vehicle placebo in a randomized, parallel-group, double-masked fashion. The subjects will have undergone routine cataract surgery on Day 0 of the study and will be assessed the next day (Post-operative Day; POD1) after uncomplicated surgery for eligibility for randomization to study treatment. The study comprises the Main Study and the Endothelial Cell Sub-study.

Study identification

NCT ID
NCT04810962
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Formosa Pharmaceuticals, Inc.
Industry
Enrollment
370 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 15, 2021
Primary completion
Jul 5, 2022
Completion
Jul 5, 2022
Last update posted
Jul 24, 2023

2021 – 2022

United States locations

U.S. sites
31
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
Arizona Eye Center Chandler Arizona 85224
Carrot Eye Center Mesa Arizona 85260
Cornea and Cataract Consultants of Arizona Phoenix Arizona 85032
Orange County Ophthalmology Medical Group Garden Grove California 92843
Premiere Practice Management, LLC Los Angeles California 90013
LoBue Laser and Eye Medical Center Inc Murrieta California 92562
Visionary Research Institute Newport Beach California 92663
North Bay Eye Associates Petaluma California 94954
Wolstan and Goldberg Eye Associates Torrance California 90505
Michael K. Tran, MD, Inc. Westminster California 92683
Rand Eye Institute Deerfield Beach Florida 33064
Eye Associates for Fort Myers Fort Myers Florida 33901
Levenson Eye Associates Jacksonville Florida 32204
International Research Center Tampa Florida 33603
Dixon Eye Care Albany Georgia 31701
Clayton Eye Clinical Research LLC Morrow Georgia 30260
Chicago Cornea Consultants Hoffman Estates Illinois 60169
Stiles Eyecare Excellence and Glaucoma Institute, PA Overland Park Kansas 66213
The Eye Care Center Louisville Kentucky 40206
Fraser Eye Center Fraser Michigan 48026
Ophthalmology Associates St Louis Missouri 63131
Wellish Vision Institute Las Vegas Nevada 89119
Metropolitan Eye Research and Surgery Institute Palisades Park New Jersey 07650
Alterman, Modi and Wolter Poughkeepsie New York 12603
Cincinnati Eye Institute Cincinnati Ohio 45242
Eye Care Specialists Kingston Pennsylvania 18704
Carolina Cataract and Laser Center Ladson South Carolina 29456
Black Hills Regional Eye Institute Rapid City South Dakota 57701
Houston Eye Associates Houston Texas 70025
DCT-Shah Research Institute LLC dba Discovery Clinical Trials Mission Texas 78572
Round Rock Eye Consultants Round Rock Texas 78681

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04810962, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 24, 2023 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04810962 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →